glp-1 news nov 2025 Pipeline Update: August - Prime Therapeutics Novo and Lilly cut GLP-1

Most side effects are temporary and diminish as your body adjusts to the compound

Zepbound for obstructive sleep apnea FDA-approved in December 2024 for moderate-to-severe obstructive sleep apnea in obese adults

For some time now I've been trying to educate physicians that nobody should be prescribed a weight loss medication like this without a co-requsite referral to a nutritionist

[2] When to Seek Medical Advice About Dizziness Whilst mild, transient dizziness may resolve with simple management strategies, certain symptoms warrant prompt medical attention

Stopping these medications suddenly can cause your appetite to spike while your metabolism struggles to adjust